Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Return on Equity (2016 - 2026)

Ekso Bionics Holdings has reported Return on Equity over the past 12 years, most recently at 1.46% for Q4 2025.

  • On a quarterly basis, Return on Equity fell 68.0% to 1.46% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.46%, a 68.0% decrease, with the full-year FY2025 number at 1.25%, down 41.0% from a year prior.
  • Return on Equity reached 1.46% in Q4 2025 per EKSO's latest filing, down from 1.09% in the prior quarter.
  • The five-year high for Return on Equity was 0.3% in Q2 2021, with the low at 1.46% in Q4 2025.
  • The 5-year median for Return on Equity is 0.82% (2024), against an average of 0.76%.
  • Peak YoY movement for Return on Equity: skyrocketed 538bps in 2021, then crashed -68bps in 2025.
  • Tracing EKSO's Return on Equity over 5 years: stood at 0.37% in 2021, then plummeted by -59bps to 0.58% in 2022, then crashed by -90bps to 1.11% in 2023, then rose by 30bps to 0.78% in 2024, then plummeted by -87bps to 1.46% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.46%, 1.09%, and 1.06% for Q4 2025, Q3 2025, and Q2 2025 respectively.